Arcutis Biotherapeutics (ARQT) Shares Outstanding: 2020-2025
Historic Shares Outstanding for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to $120.3 million.
- Arcutis Biotherapeutics' Shares Outstanding rose 2.81% to $120.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.3 million, marking a year-over-year increase of 2.81%. This contributed to the annual value of $117.8 million for FY2024, which is 21.76% up from last year.
- Per Arcutis Biotherapeutics' latest filing, its Shares Outstanding stood at $120.3 million for Q3 2025, which was up 0.41% from $119.8 million recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' Shares Outstanding ranged from a high of $120.3 million in Q3 2025 and a low of $49.9 million during Q1 2021.
- Its 3-year average for Shares Outstanding is $100.7 million, with a median of $116.5 million in 2024.
- Data for Arcutis Biotherapeutics' Shares Outstanding shows a peak YoY spiked of 89.14% (in 2024) over the last 5 years.
- Over the past 5 years, Arcutis Biotherapeutics' Shares Outstanding (Quarterly) stood at $50.3 million in 2021, then climbed by 21.45% to $61.0 million in 2022, then spiked by 58.57% to $96.8 million in 2023, then increased by 21.76% to $117.8 million in 2024, then grew by 2.81% to $120.3 million in 2025.
- Its Shares Outstanding was $120.3 million in Q3 2025, compared to $119.8 million in Q2 2025 and $119.1 million in Q1 2025.